Fried Zwartkruis

Utrecht University — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

52h-index14.2kcitations110works13.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Kinase Regulation and GTPase Signaling(18), PI3K/AKT/mTOR signaling in cancer(17), Developmental Biology and Gene Regulation(13), Cell Adhesion Molecules Research(13), Colorectal Cancer Treatments and Studies(12)

Publications110 total

The farnesoid X receptor activates transcription independently of RXR at non-canonical response elements
Nucleic Acids Research·2024· 2 citedOpen Access
mTORC1 restricts TFE3 activity by auto-regulating its presence on lysosomes
Molecular Cell·2024· 13 citedOpen Access
A YAP-centered mechanotransduction loop drives collective breast cancer cell invasion
Nature Communications·2024· 36 citedOpen Access
Direct Infusion Mass Spectrometry to Rapidly Map Metabolic Flux of Substrates Labeled with Stable Isotopes
Metabolites·2024· 2 citedOpen Access
Metabolic Alterations in NADSYN1-Deficient Cells
Metabolites·2023· 3 citedOpen Access
The malate-aspartate shuttle is important for de novo serine biosynthesis
Cell Reports·2023· 55 citedOpen Access
Maintenance of cellular vitamin B6 levels and mitochondrial oxidative function depend on pyridoxal 5′-phosphate homeostasis protein
Journal of Biological Chemistry·2023· 22 citedOpen Access
Supplementary Table S3 from A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer
2023Open Access
Supplementary Data file from A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer
2023Open Access
Supplementary Table S1 from A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer
2023Open Access
Supplementary Table S1 from A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer
2023Open Access
Supplementary Table S2 from A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer
2023Open Access
Supplementary Table S3 from A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer
2023Open Access
Supplementary Table S2 from A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer
2023Open Access
Data from A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer
2023Open Access
Data from A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer
2023Open Access
Supplementary Data file from A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer
2023Open Access
Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines
Molecular & Cellular Proteomics·2022· 4 citedOpen Access
The long-term effect of mTOR inhibition on lipid and glucose metabolism in tuberous sclerosis complex: data from the Dutch TSC registry
Orphanet Journal of Rare Diseases·2022· 11 citedOpen Access
mTOR-Activating Mutations in RRAGD Are Causative for Kidney Tubulopathy and Cardiomyopathy
Journal of the American Society of Nephrology·2021· 62 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Johannes L. Bos(20), Wolfgang Driever(14), Alexander F. Schier(13), Stephan C. F. Neuhauss(13), Jarema Malicki(13), Derek L. Stemple(13), Didier Y. R. Stainier(12), Salim Abdelilah(11), Lilianna Solnica‐Krezel(10), Zehava Rangini(9), Holger Rehmann(7), Johan de Rooij(4), Marta Roccio(4), Alfred Wittinghofer(3), Mark C. Fishman(3), Paul J. Coffer(3), Nanda M. Verhoeven‐Duif(3), Judith Jans(3), J. Belak(2), Colleen C. Boggs(2)